Ferrell Jeffrey

CIK 00013949673 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001394967

Recent Transactions

50 trades

Award
BIORA THERAPEUTICS, INC.
11.00% / 13.00% Convertible Senior Secured Notes due 2028
2024-12-12
Award
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12+5,039,236→ 5,039,236 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12+457,250→ 457,250 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12−457,250→ 0 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12+323,886→ 323,886 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
11.00%/13. 00% Convertible Senior Secured Notes due 2028
2024-08-12
Award
BIORA THERAPEUTICS, INC.
11.00%/13. 00% Convertible Senior Secured Notes due 2028
2024-08-12
Award
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12+500,249→ 500,249 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12−2,085,372→ 0 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12−5,039,236→ 0 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12−323,886→ 0 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12−500,249→ 0 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2024-08-12+2,085,372→ 2,085,372 total
Award
BIORA THERAPEUTICS, INC.
11.00%/13.00% Convertible Senior Secured Notes due 2028
2024-07-02
Award
BIORA THERAPEUTICS, INC.
11.00% / 13.00% Convertible Senior Secured Notes due 2028
2023-12-18+6,953,000→ 6,953,000 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2023-12-18+2,085,372→ 2,085,372 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
7.25% Convertible Senior Notes due 2025
2023-12-18−53,500,000→ 0 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2023-12-18+5,039,236→ 5,039,236 total
Award
BIORA THERAPEUTICS, INC.
11.00% / 13.00% Convertible Senior Secured Notes due 2028
2023-12-18+10,430,000→ 17,383,000 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
7.25% Convertible Senior Notes due 2025
2023-09-18−50,000,000→ 53,500,000 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2023-09-18+7,399,226→ 7,399,226 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2023-09-18+9,235,281→ 10,929,763 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2023-09-18+16,634,507→ 16,634,507 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2023-07-03+457,250→ 457,250 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Series X Preferred Stock
2023-01-03−42,362→ 0 total
Purchase
BIORA THERAPEUTICS, INC.
Warrant
2022-11-09+12,506,250→ 12,506,250 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2022-11-09+12,506,250→ 42,362,097 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Warrant
2022-11-09−8,097,166→ 0 total
Award
BIORA THERAPEUTICS, INC.
Warrant
2022-11-09+8,097,166→ 8,097,166 total
Purchase
BIORA THERAPEUTICS, INC.
Warrant
2021-06-14$2.47/sh+8,097,166→ 8,097,166 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2021-06-14$2.47/sh+8,097,166→ 36,396,907 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2021-06-01$2.86/sh+961,807→ 28,299,741 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2021-06-01$2.86/sh+306,308→ 28,299,741 total
Purchase
BIORA THERAPEUTICS, INC.
7.25% Convertible Senior Notes due 2025
2020-12-07$25000000.00/sh−25,000,000→ 25,000,000 total
Purchase
BIORA THERAPEUTICS, INC.
7.25% Convertible Senior Notes due 2025
2020-12-07$78500000.00/sh−78,500,000→ 78,500,000 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2020-12-07$3.27/sh+4,128,440→ 26,991,626 total
Conversion
BIORA THERAPEUTICS, INC.
Common Stock
2020-06-23+18,319,853→ 23,303,346 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2020-06-23$15.00/sh+3,333,333→ 23,303,346 total
Conversion
BIORA THERAPEUTICS, INC.
Common Stock
2020-06-23+1,250,000→ 23,303,346 total
Conversion
BIORA THERAPEUTICS, INC.
Unsecured Convertible Promissory Note
2020-06-23
Conversion
BIORA THERAPEUTICS, INC.
Series B Preferred Stock
2020-06-23−101,736,263→ 0 total
Exercise/Conversion
Apollo Endosurgery, Inc.
Restricted Stock Units
2016-03-09−3,485→ 0 total
Exercise/Conversion
Apollo Endosurgery, Inc.
Common Stock
2016-03-09+3,485→ 12,486 total
Award
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2016-02-16+25,000→ 25,000 total
Exercise/Conversion
Apollo Endosurgery, Inc.
Restricted Stock Units
2015-04-22−5,715→ 0 total
Exercise/Conversion
Apollo Endosurgery, Inc.
Common Stock
2015-04-22+5,715→ 9,001 total
Award
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2015-02-10+25,000→ 25,000 total
Exercise/Conversion
Apollo Endosurgery, Inc.
Restricted Stock Unit
2014-02-10−3,286→ 0 total
Exercise/Conversion
Apollo Endosurgery, Inc.
Class A Common Stock
2014-02-10+3,286→ 3,286 total
Award
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2014-02-10+15,000→ 15,000 total

Companies

Recent Filings

Address

C/O LPATH, INC., 6335 FERRIS SQUARE SUITE A

SAN DIEGO, CA, 92121

View on SEC.gov